TFXNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
TELEFLEX INC
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$129.68−0.75 (-0.58%)
Close on Oct 19, 2026
- Market cap
- $5.66B
- P/E (TTM)
- –
- Dividend yield
- 1.05%
Margins
Share of revenue, fiscal years 2011 to 2025
Gross margin
56.2%+4.0 pts over 5 years
Operating margin
5.9%−10.7 pts over 5 years
Net margin
-45.4%−58.7 pts over 5 years
Growth rates
Compound annual growth to fiscal 2025
| Per year | 1 year | 3 years | 5 years | 10 years | Five-year pace |
|---|---|---|---|---|---|
| Revenue | +17.2% | -10.6% | -4.7% | +1.0% | |
| Gross profit | +8.0% | -9.9% | -3.3% | +1.7% | |
| Operating income | +14.2% | -38.1% | -22.5% | -9.3% | |
| Free cash flow | -99.3% | -82.4% | -66.6% | -40.1% | |
| Dividend per share | 0.0% | 0.0% | 0.0% | 0.0% |
Returns and balance sheet
10 fiscal years. Hover a measure to see how it is calculated.
| Measure | FY2016 | FY2020 | FY2025 | Trend |
|---|---|---|---|---|
| Return on equity | 11.4% | 10.6% | -24.5% | |
| Return on assets | 6.1% | 5.0% | -12.9% | |
| Current ratio | 2.77 | 2.63 | 2.54 | |
| Debt to equity | 0.48 | 0.74 | 0.85 | |
| Net debt to EBITDA | 1.09× | 3.23× | 7.64× | |
| Interest coverage | 5.8× | 6.4× | 1.2× | |
| Inventory turnover | 2.7× | 2.4× | 2.5× | |
| Capex to revenue | 2.8% | 3.6% | 4.8% | |
| Diluted shares | 48M | 47M | 45M |
Where the cash went
Fiscal 2021 to 2025, five years combined
Teleflex generated $1.60B from operations and spent $1.20B on capital expenditure, dividends and share buybacks. 32% of that went back into the business.
Generated
$1.60B
Used
$1.20B
Capital expenditure$382.90M32%Dividends$315.14M26%Share buybacks$500.00M42%
DuPont analysis
Return on equity split into margin, efficiency and leverage
Net margin-45.4%
×Asset turnover0.28×
×Equity multiplier1.90×
=Return on equity, FY2025-24.5%
| Fiscal year | Net margin | Asset turnover | Equity multiplier | Return on equity |
|---|---|---|---|---|
| FY2025 | -45.4% | 0.28× | 1.90× | -24.5% |
| FY2024 | 4.1% | 0.23× | 1.68× | 1.6% |
| FY2023 | 20.8% | 0.24× | 1.71× | 8.4% |
| FY2022 | 13.0% | 0.40× | 1.77× | 9.3% |
| FY2021 | 17.3% | 0.40× | 1.98× | 13.7% |
| FY2020 | 13.2% | 0.38× | 2.13× | 10.6% |
| FY2019 | 17.8% | 0.41× | 2.28× | 16.7% |
| FY2018 | 8.2% | 0.39× | 2.51× | 8.1% |
| FY2017 | 7.1% | 0.43× | 2.21× | 6.7% |
| FY2016 | 12.7% | 0.48× | 1.87× | 11.4% |
Piotroski F-Score
Nine tests of profitability, balance sheet and efficiency, fiscal 2025 against fiscal 2024
5of 9 tests passed in fiscal 2025. Scores of 7 to 9 are usually read as strong.
- ProfitableNet income above zero-$905.64M
- Cash generatingOperating cash flow above zero$96.68M
- Return on assets improvedROA up on the prior year0.9% → -12.8%
- Earnings backed by cashOperating cash flow above net income$96.68M vs -$905.64M
- Less leverageLong-term debt to assets fell21.9% → 36.6%
- Better liquidityCurrent ratio rose2.27 → 2.54
- No dilutionShare count did not rise47M → 45M
- Gross margin improvedGross margin up on the prior year61.04% → 56.24%
- More efficientAsset turnover rose0.23 → 0.28